A Wegmann

873 total citations
38 papers, 330 citations indexed

About

A Wegmann is a scholar working on Epidemiology, Immunology and Surgery. According to data from OpenAlex, A Wegmann has authored 38 papers receiving a total of 330 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 7 papers in Immunology and 6 papers in Surgery. Recurrent topics in A Wegmann's work include Virology and Viral Diseases (6 papers), Hepatitis B Virus Studies (5 papers) and Food Allergy and Anaphylaxis Research (4 papers). A Wegmann is often cited by papers focused on Virology and Viral Diseases (6 papers), Hepatitis B Virus Studies (5 papers) and Food Allergy and Anaphylaxis Research (4 papers). A Wegmann collaborates with scholars based in Switzerland, United States and Sweden. A Wegmann's co-authors include K. J. Kako, R. Germanier, Stanley J. Cryz, E Fürer, Alan S. Cross, Jerald Sadoff, Reinhard Glück, K Pávek, M Just and Ezio Giacobini and has published in prestigious journals such as Nature, Journal of Clinical Investigation and The Journal of Infectious Diseases.

In The Last Decade

A Wegmann

36 papers receiving 292 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A Wegmann Switzerland 9 85 72 50 45 39 38 330
J. Verhoef Netherlands 8 114 1.3× 79 1.1× 111 2.2× 100 2.2× 44 1.1× 15 391
Joanne Marjason Australia 12 59 0.7× 79 1.1× 72 1.4× 69 1.5× 16 0.4× 17 418
Waldemar A. Palutke United States 11 200 2.4× 84 1.2× 164 3.3× 11 0.2× 30 0.8× 14 426
Howard D. Engler United States 14 332 3.9× 51 0.7× 174 3.5× 46 1.0× 31 0.8× 19 529
J. A. Maradona Spain 11 138 1.6× 30 0.4× 87 1.7× 52 1.2× 121 3.1× 24 428
Hidayeth Rostane France 9 74 0.9× 112 1.6× 34 0.7× 28 0.6× 18 0.5× 14 403
Daniel S. Selinger United States 9 132 1.6× 53 0.7× 73 1.5× 68 1.5× 48 1.2× 12 374
HENRY HIGA United States 7 34 0.4× 56 0.8× 79 1.6× 25 0.6× 70 1.8× 7 358
Schaad Ub Switzerland 11 172 2.0× 41 0.6× 62 1.2× 63 1.4× 155 4.0× 29 423
Chad R. Marion United States 9 77 0.9× 67 0.9× 35 0.7× 56 1.2× 34 0.9× 15 228

Countries citing papers authored by A Wegmann

Since Specialization
Citations

This map shows the geographic impact of A Wegmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Wegmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Wegmann more than expected).

Fields of papers citing papers by A Wegmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Wegmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Wegmann. The network helps show where A Wegmann may publish in the future.

Co-authorship network of co-authors of A Wegmann

This figure shows the co-authorship network connecting the top 25 collaborators of A Wegmann. A scholar is included among the top collaborators of A Wegmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Wegmann. A Wegmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hansen, Jan Hinnerk, Inga Voges, Olaf Jung, et al.. (2013). Impact of afterload reduction strategies on regional tissue oxygenation after the Norwood procedure for hypoplastic left heart syndrome. European Journal of Cardio-Thoracic Surgery. 45(2). e13–e19. 7 indexed citations
2.
Glück, Reinhard & A Wegmann. (1997). Influenza vaccination in the elderly. Developmental & Comparative Immunology. 21(6). 501–507. 7 indexed citations
3.
Wegmann, A & Reinhard Glück. (1996). Toward safer and more efficient pertussis vaccines. European Journal of Pediatrics. 155(2). 71–73. 1 indexed citations
4.
Wegmann, A, et al.. (1996). The history of rhesus prophylaxis with anti-D. European Journal of Pediatrics. 155(10). 835–838. 5 indexed citations
5.
Wegmann, A, et al.. (1994). [Immunogenicity and stability of an aluminum-free liposomal hepatitis A vaccine (Epaxal Berna)].. PubMed. 124(45). 2053–6. 3 indexed citations
6.
Cryz, Stanley J., Alan S. Cross, Jerald Sadoff, et al.. (1991). Safety and Immunogenicity of Escherichia coli 018 O-Specific Polysaccharide (O-PS)-Toxin A and O-PS-Cholera Toxin Conjugate Vaccines in Humans. The Journal of Infectious Diseases. 163(5). 1040–1045. 23 indexed citations
7.
Cryz, Stanley J., E Fürer, Alan S. Cross, et al.. (1987). Safety and immunogenicity of a Pseudomonas aeruginosa O-polysaccharide toxin A conjugate vaccine in humans.. Journal of Clinical Investigation. 80(1). 51–56. 83 indexed citations
8.
Wegmann, A, et al.. (1987). Hyperbaric indices (HBI) assess the extent and timing of deviant blood pressure in patients under treatment.. PubMed. 14(1). 27–30. 3 indexed citations
9.
Just, M, R. Berger, Reinhard Glück, & A Wegmann. (1986). Evaluation of a combined vaccine against measles-mumps-rubella produced on human diploid cells.. PubMed. 65. 25–7. 7 indexed citations
10.
Schwander, D, et al.. (1986). [Tolerability and pharmacokinetics of an intravenous immunoglobulin preparation in immunologically normal subjects and tolerability in patients with hypogammaglobulinemia resulting from chronic lymphatic leukemia].. PubMed. 116(5). 151–6. 1 indexed citations
11.
Bachmann, Gloria, R. Steffen, Reinhard Glück, A Wegmann, & M. Şchär. (1985). [Pre-exposure rabies vaccination using a new duck embryo vaccine].. PubMed. 115(25). 863–5. 1 indexed citations
12.
Just, M, R. Berger, Reinhard Glück, & A Wegmann. (1985). [Field trial with a new human diploid cell vaccine (HDCV) against measles, mumps and rubella].. PubMed. 115(48). 1727–30. 6 indexed citations
13.
Glück, Reinhard, et al.. (1984). [Immunogenicity of a new, highly purified, highly concentrated duck-embryo rabies vaccine].. PubMed. 114(19). 648–53. 5 indexed citations
14.
Pávek, K, A Wegmann, Lars Nordström, & D Schwander. (1982). Cardiovascular and respiratory mechanisms in anaphylactic and anaphylactoid shock reactions. Journal of Molecular Medicine. 60(17). 941–947. 27 indexed citations
15.
Pávek, K & A Wegmann. (1981). [Physiopathology of anaphylactic and anaphylactoid shock. A cooperative retrospective study].. PubMed. 99(47-48). 1994–9. 2 indexed citations
16.
Schell, K., et al.. (1980). A highly purified and concentrated duck embryo rabies vaccine: A preliminary report. Journal of Biological Standardization. 8(2). 97–106. 2 indexed citations
17.
Wegmann, A, et al.. (1976). Das Elektrokardiogramm im anaphylaktischen Schock des Menschen. Journal of Molecular Medicine. 54(10). 453–459. 4 indexed citations
18.
Wegmann, A, et al.. (1972). [Circulatory therapy in anaphylactic shock].. PubMed. 36(2). 205–6. 1 indexed citations
19.
Wegmann, A, et al.. (1962). Catecholamines in Homologous Heart Grafts.. Experimental Biology and Medicine. 109(3). 543–545. 3 indexed citations
20.
Wegmann, A, K. J. Kako, & Richard J. Bing. (1962). Catecholamine content of various organs in experimental hypertension. American Journal of Physiology-Legacy Content. 203(4). 607–608. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026